Cargando…

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy

Radiological biomarkers have been reported for multiple system atrophy and progressive supranuclear palsy, but serum/plasma biomarkers for each disorder have not been established. In this context, we performed a pilot study to identify disease-specific plasma biomarkers for multiple system atrophy a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Akio, Ishikawa, Kei-Ichi, Saiki, Shinji, Hatano, Taku, Oji, Yutaka, Okuzumi, Ayami, Fujimaki, Motoki, Koinuma, Takahiro, Ueno, Shin-Ichi, Imamichi, Yoko, Hattori, Nobutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764690/ https://www.ncbi.nlm.nih.gov/pubmed/31560709 http://dx.doi.org/10.1371/journal.pone.0223113

Ejemplares similares

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
por: Fujimaki, Motoki, et al.
Publicado: (2018)

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease
por: Saiki, Shinji, et al.
Publicado: (2017)

Metabolomics‐based identification of metabolic alterations in PARK2
por: Okuzumi, Ayami, et al.
Publicado: (2019)

Shared Metabolic Profile of Caffeine in Parkinsonian Disorders
por: Takeshige‐Amano, Haruka, et al.
Publicado: (2020)

Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease
por: Ueno, Shin‐Ichi, et al.
Publicado: (2020)

Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease
por: Yamaguchi, Akihiro, et al.
Publicado: (2020)

Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease
por: Koinuma, Takahiro, et al.
Publicado: (2021)

Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease
por: Ueno, Shin-Ichi, et al.
Publicado: (2018)

A metabolic profile of polyamines in parkinson disease: A promising biomarker
por: Saiki, Shinji, et al.
Publicado: (2019)

Non-invasive diagnostic tool for Parkinson’s disease by sebum RNA profile with machine learning
por: Uehara, Yuya, et al.
Publicado: (2021)

Systemic Metabolic Alteration Dependent on the Thyroid‐Liver Axis in Early PD
por: Miyamoto, Kengo, et al.
Publicado: (2022)

Graphic Summary of Movement Disorders Society Criteria for Progressive Supranuclear Palsy and Multiple Allocations eXtinction Rules
por: Ogawa, Takashi, et al.
Publicado: (2020)

A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia
por: Ueno, Shin-ichi, et al.
Publicado: (2020)

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
por: Okuzumi, Ayami, et al.
Publicado: (2023)

Metabolomic analysis data of MPP(+)-exposed SH-SY5Y cells using CE-TOFMS
por: Amo, Taku, et al.
Publicado: (2020)

p150(glued)-Associated Disorders Are Caused by Activation of Intrinsic Apoptotic Pathway
por: Ishikawa, Kei-Ichi, et al.
Publicado: (2014)

Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy
por: Brown, Jesse A., et al.
Publicado: (2017)

Clinical Features and Disability Milestones in Multiple System Atrophy and Progressive Supranuclear Palsy
por: Lee, Sang-Wook, et al.
Publicado: (2012)

Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease
por: Kass-Iliyya, Lewis, et al.
Publicado: (2015)

Identification of multiple system atrophy mimicking Parkinson’s disease or progressive supranuclear palsy
por: Miki, Yasuo, et al.
Publicado: (2021)

Whole-Brain Atrophy Rate in Idiopathic Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy
por: Guevara, C., et al.
Publicado: (2016)

Multi-year whole-blood transcriptome data for the study of onset and progression of Parkinson’s Disease
por: Valentine, Matthew N. Z., et al.
Publicado: (2019)

Immunohistochemical Study of Mitochondrial Ferritin in the Midbrain of Patients with Progressive Supranuclear Palsy
por: Abu Bakar, Zulzikry Hafiz, et al.
Publicado: (2021)

Whole-Brain Atrophy Differences between Progressive Supranuclear Palsy and Idiopathic Parkinson’s Disease
por: Guevara, Carlos, et al.
Publicado: (2016)

Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy
por: Jia, Peifei, et al.
Publicado: (2022)

Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learning
por: Scotton, William J, et al.
Publicado: (2023)

Genetics of Multiple System Atrophy and Progressive Supranuclear Palsy: A Systemized Review of the Literature
por: Bougea, Anastasia
Publicado: (2023)

Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy
por: Sakae, Nobutaka, et al.
Publicado: (2019)

Cerebrospinal fluid dissemination of anaplastic intraventricular meningioma: report of a case presenting with progressive brainstem dysfunction and multiple cranial nerve palsies
por: Fujimaki, Motoki, et al.
Publicado: (2016)

Zolpidem in Progressive Supranuclear Palsy
por: Dash, Sandip K.
Publicado: (2013)

Genetics of Progressive Supranuclear Palsy
por: Im, Sun Young, et al.
Publicado: (2015)

Falls in Progressive Supranuclear Palsy
por: Brown, Fraser S., et al.
Publicado: (2019)

Parkinson’s disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling
por: Mori, Akio, et al.
Publicado: (2019)

Case report: Saccadic ping-pong gaze in progressive supranuclear palsy with predominant postural instability
por: Nunomura, Hikari, et al.
Publicado: (2023)

The Economic Costs of Progressive Supranuclear Palsy and Multiple System Atrophy in France, Germany and the United Kingdom
por: McCrone, Paul, et al.
Publicado: (2011)

Force Control Deficits in Individuals with Parkinson’s Disease, Multiple Systems Atrophy, and Progressive Supranuclear Palsy
por: Neely, Kristina A., et al.
Publicado: (2013)

Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI
por: Müller, Sebastian Johannes, et al.
Publicado: (2023)

Correction to: Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learning
Publicado: (2023)

Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
por: Tsunemi, Taiji, et al.
Publicado: (2021)

‘Hummingbird’ sign in progressive supranuclear palsy
por: Shukla, Rakesh, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2vup4mf270pmlon0qj891u15si